Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions; fungicides; herbicides; insecticides; and seed treatments. Arysta LifeScience, which has more than 4,000 employees working in over 100 countries to serve customers worldwide, had 2015 revenues of US$1.8 billion.
Arysta’s “asset-lite, high-touch” business model optimizes its cost structure, resulting in greater flexibility and responsiveness to dynamic market changes. The asset-lite model involves mixing and blending ingredients supplied by others to produce unique formulations having performance characteristics that precisely target customer needs. The high-touch component of the model addresses Arysta’s skilled research and development capability enhanced by a strong commercial, marketing and technical teams that stay close to the customer.
The new Arysta LifeScience is a consolidation of three legacy businesses: Arysta LifeScience, Chemtura AgroSolutions and Agriphar. The merging of these companies gave the new entity an unrivalled combination of leading products, complementary geographies across the globe, and deep market knowledge built on a combined 270+ years of business experience. Since 2015, the Company has been a wholly owned subsidiary of Platform Specialty Products (NYSE: PAH), based in Miami, Florida.
Arysta LifeScience maintain a close connection to customers and their individualized markets by managing the business regionally with global coordination, which allows us to concentrate on identifying, marketing and delivering needed and beneficial products to high-growth markets across the globe.